Mahamaya Lifesciences Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	2,810	2,641	1,616	1,371	899.13
Other Revenue	0.87	0.87	-	0.45	0.05
Revenue	2,811	2,642	1,616	1,371	899.19
Revenue Growth (YoY)	-	63.54%	17.83%	52.50%	-
Cost of Revenue	2,394	2,267	1,391	1,184	752.95
Gross Profit	417.03	374.97	224.48	186.77	146.24
Selling, General & Admin	86.51	78.2	54.06	50.79	55.4
Other Operating Expenses	63.42	49.54	36.39	38.95	26.62
Operating Expenses	170.89	145.46	104.51	102.46	91.62
Operating Income	246.14	229.51	119.96	84.31	54.62
Interest Expense	-58.16	-55.12	-46.04	-26.33	-15.8
Interest & Investment Income	2.66	2.66	3.22	0.78	0.33
Currency Exchange Gain (Loss)	9.1	9.1	4.56	-5.88	0.1
Other Non Operating Income (Expenses)	-11.91	-12.72	-9.18	-2.13	-2.03
EBT Excluding Unusual Items	187.83	173.43	72.52	50.76	37.21
Gain (Loss) on Sale of Assets	0.19	0.19	0.18	0.21	-
Other Unusual Items	-0.03	-1.1	1.58	-	-
Pretax Income	187.99	172.52	74.28	50.96	37.21
Income Tax Expense	48.65	44.4	20.52	13.46	9.98
Net Income	139.34	128.12	53.76	37.51	27.23
Net Income to Common	139.34	128.12	53.76	37.51	27.23
Net Income Growth	-	138.31%	43.34%	37.72%	-
Shares Outstanding (Basic)	18	17	14	14	14
Shares Outstanding (Diluted)	18	17	14	14	14
Shares Change (YoY)	-	23.62%	-	-	-
EPS (Basic)	7.85	7.55	3.91	2.73	1.98
EPS (Diluted)	7.85	7.55	3.91	2.73	1.98
EPS Growth	-	92.78%	43.36%	37.88%	-
Free Cash Flow	-129	-83.49	-249.73	-17.7	-11.07
Free Cash Flow Per Share	-7.26	-4.92	-18.18	-1.29	-0.81
Gross Margin	14.84%	14.19%	13.89%	13.62%	16.26%
Operating Margin	8.76%	8.69%	7.42%	6.15%	6.08%
Profit Margin	4.96%	4.85%	3.33%	2.73%	3.03%
Free Cash Flow Margin	-4.59%	-3.16%	-15.46%	-1.29%	-1.23%
EBITDA	262.29	242.43	129.58	92.78	62.85
EBITDA Margin	9.33%	9.18%	8.02%	6.77%	6.99%
D&A For EBITDA	16.15	12.92	9.62	8.46	8.22
EBIT	246.14	229.51	119.96	84.31	54.62
EBIT Margin	8.76%	8.69%	7.42%	6.15%	6.08%
Effective Tax Rate	25.88%	25.74%	27.63%	26.40%	26.82%
Revenue as Reported	2,844	2,672	1,628	1,374	901.56

Source: S&P Global Market Intelligence. Standard template. Financial Sources.